Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.16 USD | -5.20% | +0.06% | +12.16% |
01:23pm | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
03/05 | Soleno Therapeutics Prices $138 Million Stock Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.16% | 1.73B | |
+3.80% | 108B | |
+11.01% | 104B | |
+1.28% | 22.33B | |
-12.89% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.45% | 17.64B | |
+3.73% | 14.05B | |
+36.51% | 12.51B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Soleno Therapeutics Names Meredith Manning as Chief Commercial Officer